TelyRx Holdings Inc. experienced a significant uptick in its stock price during yesterday's trading session.
TelyRx Holdings Inc. saw its stock price rise by an impressive 8.75% yesterday, closing at CA$2.61. This surge comes as the company continues to navigate its recent transition and establish its presence in the market.
Advertisement
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeAdvertisement
Market cap
$63.79M
52W high
$4.25
52W low
$2.00
1W change
+0.38%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 129.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+129.9% Upside
Current Price
C$2.61
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
111.7%
Annualized
90-Day Vol
102.6%
Annualized
Trend (90d)
-14.2%
Annualized drift
90d Mean
C$2.48
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.57 | C$1.75 – C$3.77 |
| 60 trading days | C$2.52 | C$1.46 – C$4.35 |
| 90 trading days | C$2.48 | C$1.27 – C$4.83 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors may find TelyRx's recent performance encouraging, particularly as it builds on its recent operational milestones and financial results.
TelyRx stock up 8.75% yesterday
With a market cap of CA$63.79 million, TelyRx's stock price increase signals a positive reception from investors, albeit amidst a backdrop of financial challenges.
Bull case
The recent rise in TelyRx's stock price shows that investors are gaining confidence in the company. This boost could be linked to the positive operational updates and strategic steps TelyRx has taken recently.
Bear case
Even with this positive momentum, TelyRx's ongoing net losses might worry investors about its long-term profitability and financial stability.
Advertisement
Recent Performance Highlights
TelyRx's stock price increased by 8.75% yesterday, closing at CA$2.61. This uptick is a positive sign for investors, especially as the company recently completed its qualifying transaction and began trading on the TSX under the ticker symbol 'TELY'.
Financial Outlook
While TelyRx's recent performance is encouraging, investors should remain cautious. The company reported a net loss of CA$4.7 million in its latest quarterly results, raising questions about its long-term profitability. Ongoing monitoring of TelyRx's financial health will be crucial for investors considering a stake in the company. For more details, check out the TelyRx Holdings Inc. stock page.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
